Compare ABCL & MTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | MTH |
|---|---|---|
| Founded | 2012 | 1985 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.4B |
| IPO Year | 2020 | 1997 |
| Metric | ABCL | MTH |
|---|---|---|
| Price | $9.66 | $62.14 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 10 |
| Target Price | $18.69 | ★ $69.63 |
| AVG Volume (30 Days) | ★ 2.8M | 911.4K |
| Earning Date | 11-09-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 3.13% |
| EPS Growth | ★ 10.91 | N/A |
| EPS | N/A | ★ 3.22 |
| Revenue | ★ $75,128,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.74 | $2.85 |
| P/E Ratio | ★ N/A | $19.04 |
| Revenue Growth | ★ 160.56 | N/A |
| 52 Week Low | $2.75 | $56.66 |
| 52 Week High | $14.98 | $85.38 |
| Indicator | ABCL | MTH |
|---|---|---|
| Relative Strength Index (RSI) | 34.01 | 44.39 |
| Support Level | $3.45 | $57.94 |
| Resistance Level | $12.91 | $76.89 |
| Average True Range (ATR) | 0.84 | 2.29 |
| MACD | -0.22 | -0.77 |
| Stochastic Oscillator | 2.41 | 11.06 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising twelve states: Arizona, California, Colorado, Utah, Tennessee, Texas, Alabama, Florida, Georgia, Mississippi, North Carolina, and South Carolina. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the Homebuilding segment.